Fulgent Genetics FLGT
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 40th percentile, 5-year average -7.7x
Around its usual level · 59th percentile, 5-year average 0.8x
#926 of 5329 stocks by PB (1 = cheapest)
Around its usual level · 53rd percentile, 5-year average 2.1x
#2615 of 5156 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 0.70 | – | 0.80 | 59% (pricier than usual) | #926 of 5329 (1 = cheapest) |
| PE | -7.95 | -7.49 | -7.71 | 40% (cheaper than usual) | – |
| PS | 2.09 | 1.89 | 2.08 | 53% (pricier than usual) | #2615 of 5156 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on FLGT.
Sign in to join the discussion.